Fluofarma

France

Back to Profile

1-2 of 2 for Fluofarma Sort by
Query
Aggregations
IPC Class
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin 1
A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA] 1
A61P 35/00 - Antineoplastic agents 1
C07C 209/16 - Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings 1
C07C 229/14 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings 1
See more
Found results for  patents

1.

SYSTEM AND METHOD TO VISUALIZE AND ANALYZE DATA FROM IMAGE-BASED CELLULAR ASSAYS OR HIGH CONTENT SCREENING

      
Application Number EP2012056928
Publication Number 2012/140264
Status In Force
Filing Date 2012-04-16
Publication Date 2012-10-18
Owner FLUOFARMA (France)
Inventor
  • Racine, Victor
  • Berard, Fanny
  • Ichas, François
  • De Giorgi, Francesca

Abstract

Data processing system for generating representations and analyses of cytometric information for: - loading one set of data including: - one image of two wells on a plate each having one cell in a predetermined biological condition, each image being acquired with a microscope; - features of each cell from each image; - processing loaded data for obtaining representations and analyses of the data, from: - Histogram in one dimension; - Scattergram in two-dimensions; - Density in two-dimensions; - Plate layout management; - Cell montage; - Field; - Plate heatmap; - Dose response with regrouping of replicates; - Statistics information like percentage of cell in different gates; - zFactor calculation with regrouping of replicates; - List of well for selection and list of biological condition for selection; - Statistics export capability; - Ready to print layout capability on the selected well or biological condition or all wells and biological conditions.

IPC Classes  ?

  • G06F 19/26 - for data visualisation, e.g. graphics generation, display of maps or networks or other visual representations

2.

TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS

      
Application Number FR2007000703
Publication Number 2007/125196
Status In Force
Filing Date 2007-04-25
Publication Date 2007-11-08
Owner
  • FLUOFARMA (France)
  • UNIVERSITE BORDEAUX 1 (France)
  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
Inventor
  • Depierre, Gaëlle
  • Dessolin, Jean
  • Laguerre, Michel
  • Commandeur, Claude

Abstract

This invention relates to compounds with the formula (I) given below or one of their pharmaceutically acceptable salts, as a medicine; Formula (I) of pharmaceutical compositions comprising one or more compounds with Formula (I) as active constituent, use of compounds with Formula (I) for the preparation of compositions designed to prevent or treat at least one illness involving an abnormal cellular proliferation, pro-apoptotic compositions and/or anti-proliferative compositions comprising at least one compound with Formula (I)/ and the use of compounds with formula (I) as pro-apoptotic and/or anti-proliferative agents.

IPC Classes  ?

  • C07C 271/22 - Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
  • C07C 229/14 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
  • A61P 35/00 - Antineoplastic agents
  • C07C 233/31 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
  • C07C 235/78 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
  • C07C 237/06 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
  • C07C 237/08 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
  • C07C 271/20 - Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
  • C07C 311/02 - Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
  • C07C 327/22 - Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
  • C07C 327/40 - Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
  • C07C 209/16 - Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings